|
|
Eli Lilly & Co
XETRA •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/27/2026 17:35
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization1,020,247 mln
Float848 mln
Earnings Date10/29/2026
Key Fundamentals
EPS26.21
P/E43.83
ROE99.90
RPS79.69
ROIC30.81
ROA22.74
Interest Cover131
EBITDA, mln30,866
EV / EBITDA30.66
EV / EBIT32.56
Revenue, mln68,318
EV / Revenue13.86
Quote Details
Last
1,149.00
Change
5.2 (0.45%)
Open
1,150.00
Volume
430
Turnover
494,070
Average Volume
1,443.43
Financial Ratios
Pre-Tax Profit Margin42
Leverage Ratio4.20
Current Ratio1.36
Price / Book33.24
Price / Tangible Book163
Price / Cash Flow40.47
Price / Free Cash Flow59.05
Debt / Equity1.62
Price / Sales13.62
PEG Ratio1.43
Financial Strength
Altman Z-Score7.97
Piotroski F-Score
9
/ 9
Beneish M-Score-2.04
Price to Intrinsic Value8.67
Price to Lynch Fair Value1.40
Price to Graham Number15.93
Shiller PE Ratio125
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-0.52% |
22
/ 100
 |
| 1 Month |
10.16% |
92
/ 100
 |
| 2 Months |
10.26% |
87
/ 100
 |
| 6 Months |
40.18% |
97
/ 100
 |
| 1 Year |
64.07% |
97
/ 100
|
|
| |
